Form EFFECT Xilio Therapeutics, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 29, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Zefiro Announces Closing of Non-Brokered Private Placement for Gross Proceeds of Approximately C$3.3 Million from Strategic Investors
- Morvulikent Analyzed 2026: Should You Trust Morvulikent AI-Powered Trading Platform? My Honest Review
- PHX Energy Services Corp. Announces Quarterly Dividend
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
